Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00032743
DRKS00032743
Recruiting
Not Applicable

Observational study to evalute patient satisfaction with different oral cannabis products - SATUR

Avextra Pharma GmbH0 sites500 target enrollmentOctober 17, 2023
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsPatients (cannabis-naïve / cannabis-experienced) with a diagnosed disease for which medical cannabis is indicated in the sense of the Cannabis as Medicine (CAM) Act.

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Patients (cannabis-naïve / cannabis-experienced) with a diagnosed disease for which medical cannabis is indicated in the sense of the Cannabis as Medicine (CAM) Act.
Sponsor
Avextra Pharma GmbH
Enrollment
500
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 17, 2023
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Avextra Pharma GmbH

Eligibility Criteria

Inclusion Criteria

  • •1\. Patients of any gender and ethnicity aged 18 years or older (both cannabis\-naïve and cannabis\-experienced).
  • •2\. Documented diagnosis of a condition for which cannabis as a medicine (CAM) is indicated (and has been and is being used according to the 2022 BfArM companion survey), e.g. for (but not limited to):
  • •\- Chronic musculoskeletal pain
  • •\- Neuropathic pain
  • •\- Chronic tumour\-related pain
  • •\- Use in palliative care (e.g. inappetence, nausea, pain)
  • •\- Spasticity, e.g. caused by multiple sclerosis
  • •\- anorexia
  • •\- Gastrointestinal diseases (e.g. Crohn's disease, ulcerative colitis)
  • •\- Sleep disorders

Exclusion Criteria

  • •1\. Any other condition, disorder or observation which, in the opinion of the investigator, would interfere with the participant's ability to complete the study survey.
  • •2\. Hypersensitivity/allergy to THC or CBD or the other components of the respective dosage form.
  • •3\. Psychiatric illness related to schizophrenia/psychosis.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
An observational study on patients' satisfaction with oral pain medicationsPain/neuralgia
JPRN-UMIN000036456ihon Chouzai Co.,Ltd.781
Completed
Not Applicable
A prospective study examining patient satisfaction and sleep analysis data in drug therapy for patients with insomnia.
JPRN-jRCT1031210223Sone Masayoshi17
Not yet recruiting
Not Applicable
A Study for satisfaction related to artificial limb in lower limb amputeesHealth Condition 1: M968- Other intraoperative and postprocedural complications and disorders of musculoskeletal system, not elsewhere classified
CTRI/2024/02/062353PGIMER post graduate institute of medical education and research Chandigarh
Recruiting
Not Applicable
Clinical prospective Study for Patient Satisfaction with dental ImplantsPatient Satisfaction with dental implants
DRKS00022979Praxis Prof. Dr. Dr. Stoll und Partner196
Not yet recruiting
Not Applicable
Investigation of patient satisfaction following use of the VERASENSE sensor to monitor operative contact pressure during TKAOsteoarthritis Rheumatoid Arthritis Osteonecrosis
JPRN-UMIN000039794Fujita health university50